Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$314,512.00
May 5, 2025
For-profit organization
Next-Generation Resorbable and Long-Term Hollow/Porous Glass Microspheres for Precision Transarterial Embolization.
1030534
This project aims to develop resorbable hollow/porous/solid glass microspheres for precision transarterial embolization (TAE), with long-term variants as an additional option. Unlike permanent embolic agents, the resorbable radiopaque microspheres provide temporary occlusion, precise imaging, and safe, controlled degradation. Objectives include synthesizing tunable glass microsphere compositions, optimizing their structure for payload and delivery efficiencies, and confirming effectiveness in preclinical models. These versatile, biocompatible microspheres enhance TAE precision, minimize long-term risks for temporary embolization needs, and set a new benchmark in interventional radiology.
$2,999,699.00
Feb 22, 2018
208491
208491
Design, develop and attain quality approval for manufacture of microspheres
$49,500.00
Dec 12, 2014
204934
204934
Engage expertise to oversee the technical design and development of products
$2,140,000.00
Nov 18, 2014
203172
203172
Develop and commercialize next generation medical devices for interventional radiology
$50,000.00
Dec 19, 2012
201899
201899
Hire a new CEO to advance the commercialization of the company's medical devices
$499,975.00
Oct 12, 2012
201431
201431
Development of technology to support the treatment of uterine fibroids